Breakthrough Economy: Innovation in Immuno-Oncology

Breakthrough economy: innovation in immuno-oncology

Nasdaq published this video item, entitled “Breakthrough Economy: Innovation in Immuno-Oncology” – below is their description.

In this episode of Breakthrough Economy, we discuss innovations and challenges in the immuno-oncology space. Host Jen Rogers is joined by Niko Kley, co-founder and CEO of Orionis Biosciences and Dr. Pam Sharma, Professor and Director of Scientific Programs for the James P. Allison Institute at MD Anderson Cancer Center.

Learn more:

Nasdaq YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

About This Source - Nasdaq

Nasdaq, Inc. is an American multinational financial services corporation that owns and operates three stock exchanges in the United States: the namesake Nasdaq stock exchange, the Philadelphia Stock Exchange, and the Boston Stock Exchange, and seven European stock exchanges: Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, and Nasdaq Vilnius. It is headquartered in New York City, and its president and chief executive officer is Adena Friedman.

Recent from Nasdaq:

Technical Levels to Watch in the Nasdaq-100 and Nasdaq-100 Volatility Index

Technical Levels to Watch in the Nasdaq-100 and Nasdaq-100 Volatility Index

Semiconductor Fundamentals and Sources of Future Growth

Leave a Comment

We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.